News
-
New Regulation Bulletin
1. New FDA Registration Regulations for U.S. Cosmetics Cosmetics Without FDA Registration Will Be Banned from Sale.According to the Modernization of Cosmetics Regulation Act of 2022, signed by President Biden on December 29, 2022, all cosmetics exported to the United States must be FDA-registere...Read more -
2023 The 88th API CHINA
Information about JYMed at 2023 API CHINA 【on-site】 Under the leadership of Vice General Manager Zhi Qin, Shenzhen JYMed Technology Co.,Ltd. (hereinafter referred to as JYMed)participated in this grand exhibition. JYMed showcased advantageous products Semaglutide, Liraglutide, Tirzepatide, O...Read more -
Welcome to meet us at API exhibition at Qindao China JYMed stock: N4K32
Read more -
JYMed got together with you at PCHi
After two years of expectation, the 2023 China International Cosmetics Personal and Home Care Raw Materials Exhibition (PCHi) had been held in the Guangzhou Canton Fair Complex on February 15-17, 2023. PCHi is an international trade show serving the global cosmetics, per...Read more -
Semeglutide API of Shenzhen JYMed accepted by the first batch of domestic NMPA and Registered in US FDA (DMF No. 036009) with status “A”.
In May 2022, Shenzhen JYMed Technology Co., Ltd. (hereinafter referred to as JYMed peptide) submitted an application for the registration of semaglutide API to the US Food and Drug Administration (FDA) (DMF registration number: 036009), It has passed the integrity review, and the current status i...Read more
